Annual Drug Patent Expirations for CORLANOR
Corlanor is a drug marketed by Amgen Inc and is included in two NDAs. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for CORLANOR.
This drug has ninety-one patent family members in forty-three countries.
The generic ingredient in CORLANOR is ivabradine hydrochloride. One supplier is listed for this compound. Additional details are available on the ivabradine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
